Pacific Biosciences Of California (PACB) Cost of Revenue (2011 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Cost of Revenue of $24.3 million for Q1 2026, down 36.83% year-over-year from $38.5 million in Q1 2025, and down 13.33% quarter-over-quarter from $28.1 million in Q4 2025.
Pacific Biosciences Of California (PACB) Cost of Revenue (2011 - 2026) Analysis & Trends
Pacific Biosciences Of California's Cost of Revenue history runs 16 years deep, the most recent figure standing at $24.3 million for Q1 2026.
- In Q1 2026, Cost of Revenue fell 36.83% year-over-year to $24.3 million; the TTM figure through Mar 2026 stood at $100.0 million (down 21.68% YoY), while the FY2025 annual figure was $114.2 million, down 2.15% from the prior year.
- Cost of Revenue for Q1 2026 stood at $24.3 million, down from $28.1 million in the prior quarter.
- The five-year high for Cost of Revenue was $48.8 million in Q4 2023, with the low at $18.8 million in Q3 2022.
- The 5-year median for Cost of Revenue is $28.1 million (2025), against an average of $28.4 million.
- Peak annual rise in Cost of Revenue reached 472.31% in 2022, while the deepest fall reached 63.48% in 2022.
- Pacific Biosciences Of California's Cost of Revenue stood at $22.2 million in 2022, then soared by 119.63% to $48.8 million in 2023, then slumped by 40.22% to $29.2 million in 2024, then fell by 3.73% to $28.1 million in 2025, then declined by 13.33% to $24.3 million in 2026.
- Business Quant data shows PACB's Cost of Revenue at $24.3 million in Q1 2026, $28.1 million in Q4 2025, and $22.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 5.33 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 2.09 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 1.59 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 392.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 478.40 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 2.57 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 808.60 Mn |
| 10 | Pacific Biosciences Of California | 400.74 Mn | 163.87 Mn | 12.64 Mn | 26.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.37 Mn |
| Jun 30, 2026 | 26.37 Mn |
| Mar 31, 2026 | 24.34 Mn |
| Mar 31, 2026 | 24.34 Mn |
| Dec 31, 2025 | 28.08 Mn |
| Dec 31, 2025 | 28.08 Mn |
| Sep 30, 2025 | 22.54 Mn |
| Sep 30, 2025 | 22.54 Mn |
| Jun 30, 2025 | 25.08 Mn |
| Jun 30, 2025 | 25.08 Mn |
| Mar 31, 2025 | 38.52 Mn |
| Mar 31, 2025 | 38.52 Mn |
| Dec 31, 2024 | 29.17 Mn |
| Dec 31, 2024 | 29.17 Mn |
| Sep 30, 2024 | 29.96 Mn |
| Sep 30, 2024 | 29.96 Mn |
| Jun 30, 2024 | 30.08 Mn |
| Jun 30, 2024 | 30.08 Mn |
| Mar 31, 2024 | 27.53 Mn |
| Mar 31, 2024 | 27.53 Mn |